calcium channel blockers
use in patients with advanced renal disease, especially in cases of diabetic nephropathy. It should be investigated Sir, whether or not earlier stages of this nephropathy are also I read with interest the article 'Preservation of renal function: affected negatively by these agents. the spectrum of effects by calcium channel blockers' [1] . Five Hospital Universitario de la Princesa R. Selgas years ago, I published a paper on follow-up of residual renal Servicio de Nefrologia function in continuous ambulatory peritoneal dialysis c/ Diego de Leó n, 62 (CAPD) patients [2] which obtained very similar results to E-28006 Madrid, Spain those summarized in the review by Tarif and Bakris. Since that paper was published in Spanish, I would like to take this opportunity to present a brief summary of the results to 1. Tarif N, Bakris GL. Preservation of renal function: the spectrum corroborate the idea that dihydropiridine calcium channel of effects by calcium-channel blockers. Nephrol Dial Transplant 1997; 12: 2244 -2250 blockers (DHPCCBs) do not confer protection to the kidney 2. Borrego F, Selgas R, de Alvaro F et al. Seguimiento de la funció n in diabetic nephropathy. On the contrary, these agents could renal residual en pacientes en diálisis peritoneal continua accelerate the loss of renal function especially in diabetic ambulatoria patients on peritoneal dialysis.
In the study we performed [2] , 38 patients for whom CAPD was the first dialytic therapy, maintained on peritoneal Reply dialysis for at least 3 years and with an initial diuresis >100 ml/day were selected. After 2 years on CAPD, residual creatinine clearance (RCC ) significantly declined from Sir, 4.0±2.6 to 1.6±1.8 ml/min (P<0.01). At this time, only We read with interest the letter by Dr Selgas. We were not 50% of the patients showed RCC values >1 ml/min. Diabetic aware that data on renal function decline with dihydropyridine calcium antagonists (DHPCAs) were available from patients had a higher RCC than non-diabetics (5.8±3 vs patients with end-stage renal disease. While the author's data 3.1±1.8, P<0.01) when starting CAPD. After 1 and 2 years corroborate our own, his plea for studies to evaluate these on CAPD, diabetic patients showed a more severe decline antihypertensive agents in earlier stages of diabetic nephroin RCC than non-diabetics (−1.8±3.1 vs −0.8±1.5 ml/ pathy, while warranted, will never be met. This is true for min/year for the first year, and −4.9±3.2 vs −0.9±2.0 ml/ two reasons: first, in order to evaluate fully the effects of min/year, for the second year, both P<0.01). Gender, daily DHPCAs on renal disease progression, i.e. time to dialysis, protein intake estimated by nPCR, weight, blood pressure, in patients with microalbuminuria whose serum creatinine is incidence of peritonitis, administration of nephrotoxic anti-<1.5 mg/dl, >3000 patients followed for a minimum of 7 biotics, serum biochemistry and peritoneal function data did years would be required. Second, funding this type of project not show any influence in the slope of RCC loss. However, would be quite difficult. Consequently, the feasibility of such the patients receiving calcium channel blockers (nifedipine), a study, especially in light of data from the recent ABCD showed a more significant decrease in RCC than those not and FACET trials, is remote [1, 2] . I must also add that the receiving these drugs (−3.1±3.1 vs −1.0±2.2 ml/min/year, recently completed clinical trial in hypertensive non-diabetic P<0.05). This difference was more impressive in diabetics patients without nephropathy i.e. the Hypertension Optimal albeit with a similar control of blood pressure. The decrease Treatment (HOT ) trial utilized a DHPCA to lower blood in RCC in this particular group between the first and the pressure and was not stopped earlier due to cardiovascular second year on CAPD was −2.5±1.8 (for those not receiving events. Also, the ongoing 40 000 patient ALLHAT trial has DHPCCBs) vs −4.2±2.3 ml/min/year (for those receiving not been stopped, thus far, due to abnormally high cardiovasDHPCCBs) (P<0.01). Angiotensin-converting enzyme cular events. Thus, it appears that the people who fail to be inhibitors and b-blockers showed no influence on these protected against renal or cardiovascular events are those parameters.
with pre-existing diabetic nephropathy. Lastly, it should also Although our results were obtained in patients on dialysis, be noted that fixed dose combinations of an angiotensinit is recognized that preservation of renal function is a converting enzyme (ACE ) inhibitor with a DHPCA have characteristic of peritoneal dialysis for reasons not well shown renal protection whereas the DHPCA alone, in spite clarified at the present. Our data support the contention that of blood pressure reduction, has failed to show such protecpharmacological agents may play an important role in detertion [3] . This is not true for non-DHPCAs (verapamil or mining the residual renal function outcome. The coincidence diltiazem) that potentiate antiproteinuric effects of ACE with the data of Tarif and Bakris [1] reinforce the existence inhibitors as well as renal protection [4] . Thus, it appears of a particular action of DHPCCBs on glomerular permeabilthat once renal disease is present, especially in the presence ity independent of their effects on blood pressure. The of diabetes, DHPCAs should either not be used or used with vasodilation of afferent arterioles induced by these agents ACE inhibitor to lower blood pressure. could cause an increase in glomerular membrane permeability to plasma proteins which are able to accelerate mesangial Department of Preventive Medicine George L. Bakris sclerosis. In the case of spontaneous outcome of diabetic Luke's Medical Center nephropathy, this has been recognized as particularly 1725 W. Harrison Street Chicago, IL 60612, USA relevant.
1. Tatti P, Guarisco R, Pahor M, Strollo G, Byington RP, Strollo F, 3. Bakris GL, Griffin KA, Picken MM, Bidani AK. Combined effects of an angiotensin converting enzyme inhibitor and a Di Mauro P. Outcome results of the fosinopril versus amlodipine cardiovascular events randomized trial (FACET ) [1] . In this report, the authors described four cases of amyloidosis associated with chronic infected kidneys and only one associated with xantogranulomatous pyelonephritis. This association is very infrequent and to our knowledge only seven patients with xantogranulomatous pyelonephritis and AA-amyloidosis have been described to date [1] [2] [3] [4] [5] . We report a new case of secondary amyloidosis associated with xantogranulomatous pyelonephritis.
A 74-year-old woman presented with a history of recurrent, bilateral renal colics and urinary tract infections, some years oedema and moderate arterial hypertension. She was admitted to our hospital because of fever, chills, hypotension and renal impairment (serum creatinine 4 mg/dl ). Ultrasonography revealed a calculus in the right ureter, destructed parenchyma and multiple scattered abscesses on the right kidney. The left kidney was hydronephrotic due to high ureteral lithiasis. Urgent surgery was performed, i.e. nephrectomy of the right kidney and double-J catheter drainage of the left ureter. Septic symptoms and renal function improved soon after nephrectomy and antibiotic therapy. However she presented massive proteinuria and hypoalbuminemia. The nephrectomy piece showed diffuse infiltration with foamy, lipid-filled macrophages typical of a xantogranulomatous pyelonephritis (Figure 1 ). We looked for amyloid deposits because of nephrotic proteinuria. After Congo Red staining, reddish pink deposits were found in glomeruli, vessels and interstitium; furthermore with immunohistochemical stain using antiserum against AA amyloid protein combined with immunoperoxidase, protein AA was found in the above structures (Figure 2 ). During Fig. 2 . Glomerulus with deposition of AA protein (monoclonal follow-up, she was treated with ACE inhibitors and diuretics. antihuman amyloid A component, combined with immunoRenal function was stabilized and blood pressure controlled. peroxidase staining, Dako Diagnostics, ×40). Proteinuria decreased, and 6 months later the nephrotic syndrome remitted (proteinuria 1 g/day). Moreover, she fat or rectal biopsy [1, 2, 4] . The patients with this particular developed overt hypercalcaemia (11-12 mg/dl ) with elevated form of secondary amyloidosis have the following features: serum levels of parathyroid hormone, suggesting primary (i) history of lithiasis and recurrent urinary tract infection hyperparathyroidism.
[1,3]; (ii) development of nephrotic range proteinuria with The appearance of significant proteinuria in patients with renal impairment, with a more aggressive evolution than in persistently obstructed and infected kidneys should alert the classic systemic amyloidosis [1]; (iii) coexistence of pyeloclinician to the possibility of secondary amyloidosis, as noted nephritis and amyloid deposition in nephrectomy specimens in our patient [1] . It is necessary to look for amyloid deposits [1, 2, 4] , and (iv) improvement of proteinuria and renal in nephrectomy specimens, using adequate techniques [2] . insufficiency after removal of the infective focus by nephrectomy in almost all cases [1, 2, 4] . Our patient had all these Alternatively, amyloid may be documented in subcutaneous electron dense material was noted. At higher magnifications AB. Recombinant human uteroglobin suppresses cellular invas-this material was observed to be non-fibrillar in appearance.
iveness via a novel class of high-affinity cell surface binding site.
The patient was given oral cyclophosphamide
Proc Natl Acad Sci USA 1996; 93: 2915 -2919 400 mg/m2/day and prednisolone 100 mg/m2/day for 5 days and intravenous vincristine at a dose of 1.4 mg/m2 as a single dose on the first day of treatment. Following the first course Nephrotic syndrome associated with chronic of CVP, she had complete remission with disappearance of lymphocytic leukaemia splenomegaly and lymphadenopathies and with an absolute lymphocyte count below 5×109/l. An accompanying improvement in renal function and disappearance of the Sir, nephrotic syndrome was also observed with a BUN of Whilst the association of nephrotic syndrome with neoplastic 22 mg/dl, a serum creatinine of 1.4 mg/dl, and negligible diseases, particularly carcinomas and lymphomas is well proteinuria (Table 1) . known [1] , nephrotic syndrome associated with chronic
In comparison to other B-cell lymphoproliferative dislymphocytic leukaemia (CLL) is less common with an estimorders, clinical glomerular pathology has been less frequently ated incidence of 1-2% [2] . About 60 cases of glomerular described in CLL but an autopsy series has shown that the lesions have been reported up until 1997 [1] [2] [3] [4] [5] . The most incidence of extraglomerular renal lesions such as subclinical common glomerular lesion is membranoproliferative glominterstitial lymphocytic infiltration and tubular atrophy is erulonephritis (MPGN ) which accounts for approximately 60-70% in patients with CLL [1] [2] [3] . A variety of glomerular 45% of reported cases [2, 3] . We report a case of CLL lesions have been described in CLL, including type I and II presenting with nephrotic syndrome in whom percutaneous MPGN, focal and diffuse proliferative glomerulonephritis, renal biopsy not only revealed membranoproliferative glommembranous glomerulonephritis, light-chain nephropathy, erulonephritis (MPGN ) type I but also focal areas of minimal-change disease, fibrillar glomerulopathy, and amyllymphocyte infiltration. Clinical manifestations of CLL and oidosis [1] [2] [3] [4] [5] . Unlike other malignancies which are mostly nephrotic syndrome resolved with chemotherapy consisting associated with membranous glomerulopathies, CLL is of cyclophosphamide, vincristine and prednisolone (CVP).
mainly associated with MPGN type I and II [2], although A 63-year-old woman presented to the outpatient clinic in the reason for this remains unexplained and immune complex July 1995 complaining of fatigue, anorexia, weight loss of disease may underlie the lesion. Some of the glomerulo-15 kg over the previous 8 months, and easy bruising. On nephritis in CLL has been suggested to be related with physical examination the patient was pale and had bilaterally glomerular involvement by deposition of the processed cryopalpable rubbery axillary and inguinal lymph nodes, spleen precipitating or non-cryoprecipitating M-component [2] [3] [4] . enlargement, and moderate bilateral pretibial and ankle Though in our patient with MPGN, neither circulating oedema.
immune complexes or cryoglobulin were detected, electron Investigations revealed a haemoglobin of 8.6 g/dl, a white microscopy revealed presence of non-fibrillar material blood cell ( WBC ) count of 92×109/l with 95% mature beneath the endothelium of the basement membrane. The lymphocytes, and a platelet count of 324×109/l. She also electron microscopic appearance of the deposits in kidneys had renal impairment with a blood urea nitrogen (BUN ) of of patients with CLL and cryoglobulinaemia has been 65 mg/dl, a serum creatinine of 2 mg/dl, and a serum albumin of 3 g/dl. The urinary sediment contained many red blood reported to be fibrillar [6 ] ; however, due to failure in immunofluorescence visualizing, the nature of the material disturbance in such patients [3] . We observed a case of adult HUS, with fatal ventricular tachycardia. in our patient remains speculative.
Remission of the nephrotic syndrome occurring with CVP treatment may be a result of the effects of cyclophosphamide
Case report
and prednisolone directly on the kidney or alternatively improvement in renal function may have occurred as a result
An 18-year-old male patient was admitted to Nephrology of remission of the CLL. That the latter is more likely is Unit of our hospital with acute onset progressive swelling supported by data from Moulin et al. [3] , where treatment preceded by upper respiratory tract infection for 6 weeks, of four patients with CLL and MPGN with chlorambucil oligoanuria, haematuria, anorexia, nausea, and vomiting for alone in the absence of steroids resulted in complete remission 4 weeks and impaired sensorium of 3 days duration. The of nephrotic syndrome in all patients with a parallel improvepatient had been well and asymptomatic until 8 weeks before, ment in their CLL. This improvement occurred despite the when he developed cough, running nose, and mild fever, for fact that MPGN normally has a poor prognosis, and chlorwhich he did not seek medical consultation. However, he ambucil is rarely used in the treatment.
denied any history of diarrhoea. Over the next 5-6 days, he Departments of Haematology Tü lin Budak-Alpdoǧan noticed swelling over face and feet, which gradually increased Nephrology, Histology Ö nder Alpdoǧan in severity in a week's period. Subsequently he developed and Embryology I =mer Okar decreased urine output (progressing to anuria) and haematMarmara University Hospital Emel Akoǧlu uria. He sought medical advice at this stage of illness and Istanbul, Turkey was prescribed some medication, the nature of which was not known. He developed anuria (urine volume 100 ml/day) and uraemia with weakness, anorexia, breathing difficulties, 
Recurrent ventricular tachycardia complicating atypical
ECG showed ventricular tachycardia (Figures 1 and 2 ). DC haemolytic-uraemic syndrome cardioversion with 160 joules was attempted and rhythm reverted back to normal. There was no evidence of electrolyte imbalance. He was put on oral mexiletine therapy 150 mg Sir, Thrombotic microangiopathy is the underlying pathological thrice a day. Twelve hours following the first episode, he developed ventricular tachycardia again and sinus rhythm lesions in haemolytic-uraemic syndrome [1] . The cardiac manifestation in the form of congestive heart failure and was restored with DC defibrillation. In the following day, he again had similar episode which reverted back to normal arrhythmia have been reported in thrombotic thrombocytopenic purpura [2] . Thrombi and haemorrhage in the con-with DC cardioversion. Intravenous lignocaine infusion was started. Same day he had another episode of ventricular ducting tissue may account for cardiac arrest and rhythm tachycardia 2 h later, when sinus rhythm could not be with AV dissociation had been reported suggesting pathology in the conducting tissue. Our patient had ECG evidence of restored and he succumbed to the ventricular tachycardia.
Laboratory investigations revealed Hb 6.2 g/dl, TLC recurrent ventricular tachycardia. Because cardiac monitoring was not done in most of these patients, transient 11 900/mm3, neutrophils 69%, lymphocytes 28%, monocyte 3%, platelet counts 94 000/mm3, blood smears showed throm-arrhythmia would have gone undetected. Since thrombi and haemorrhage are common findings in the conducting tissue bocytopenia, schistocytes, Burr cells, and helmet cells. Reticulocyte count was 16%, Prothrombin time 13.7 s (con-of heart, it may account for cardiac arrest, arrhythmia or even sudden death [2, 3] . Therefore ECG monitoring trol 12.7 s), serum bilirubin 1.7 mg/dl, serum amylase 110 IU/l, SGOT 62 IU/l, SGPT 74 IU/l, blood urea 248 mg/dl, seems to be essential in patients with haemolytic-uraemic syndrome. serum creatinine 12.3 mg/dl, serum sodium 129 mmol/l, potassium 4.2 mmol/l, chloride 98 mmol/l, blood glucose
In conclusion, beware of fatal cardiac arrhythmia in patients with haemolytic-uraemic syndrome. 120 mg/dl, 24 h urinary protein 3.3 g.
Renal biopsy showed enlarged glomeruli with segmental Department of Nephrology Jai Prakash mesangial proliferation, focal glomerular basement mem-Institute of Medical Sciences S. Gupta brane thickening and thrombi in capillary loops. Blood Banaras Hindu University H. Kumar vessels showed mucoid degeneration of intima, fragmented Varanasi-221 005 Usha endothelial lining, mural thrombus with fibrinoid necrosis of India Bharat Rawat intertubular capillaries. Acid fuschin orange G (AFOG) staining showed focal fibrinoid deposits and thrombi in glomerular capillary loops. Thus, the renal histology was 1. Symmers WSTC. Thrombotic microangiopathic haemolytic anaemia (thrombotic microangiopathy) Br Med J 1952; 2: 897-903 consistent with haemolytic-uraemic syndrome. However, thrombi and haemorrhagic foci were not identified Sir, On the recommendation of the WHO, most countries opted in the sinoatrial node, or in the bundle-branch part of the conducting tissue. In addition to cardiac arrythmias, myocar-for the universal vaccination against hepatitis B. Cases of different immune diseases following vaccination (mainly ditis, and cardiomyopathy have also been reported in haemolytic-uraemic syndrome [4, 5] . ECG evidence of bradycardia against flu and hepatitis B) are increasingly reported: polyarthritis, vascularitis, erythema nodosum, uveitis, auto-Interstitial nephritis and retinitis pigmentosa immune thrombopenia, Guillain Barré syndrome, multiple sclerosis. However these published observations (although Sir, underestimated) have limited significance because no causal-We have read with great interest the new syndrome with ity has been demonstrated, only a chronological link with familial interstitial nephritis and retinitis pigmentosa the vaccination.
described by Farrell et al. [1] . Herein, we report a similar We report here an observation of two different autoimmune case of a girl who was born in 1980. In 1994 a cyst was diseases occurring in two members of a family vaccinated removed from her left breast. In 1995, she was investigated against hepatitis B.
because of a headache; fundoscopy and ERG revealed retinMrs O., aged 24, in good health, is the mother of three itis pigmentosa. That time she had 1 g/day proteinuria. In children. No previous history has been noted in this family. 1997, she was admitted to our nephrological centre to In February 1995, Mrs O. and her three children began a investigate her persistent proteinuria. Serological examinacourse of intramuscular vaccination against hepatitis B tion on admission included: serum creatinine 75 mmol/l, urea (recombinant vaccine), three vaccinations every month and 5.4 mmol/l, Cl cr 117 ml/min, potassium 3.7 mmol/l, haemoa booster in February 1996. globin 12.5 g/dl, albumin 36 g/l, normal urinary sediment, In December 1995, one of her daughters, aged 7, com-proteinuria 0.5-1.5 g/day. PAGE revealed a non-selective plained about subcutaneous haematomas and bleeding gums. proteinuria: SI (MMW/HMW ) 4.57. The acid-loading test Her platelet count was 24×106/l. A diagnosis of idiopathic with ammonium chloride was normal. The exogenous AVP thrombopenic purpura (ITP) was made in January 1996. In test found impaired concentrating capacity: maximal urine April 1996, Mrs O.'s general state of health changed, she osmolality 778 mosm/l, maximal specific gravity 1020. exhibited marked loss of weight, and migratory arthralgia. Immunological tests (immunoglobulins, rheumatoid factor, Acute disseminated lupus erythematosus (SLE) was dia-complement factors, CRP, cryoglobulin, ANA, ANCA) were gnosed in March 1997 with four criteria of the ARA normal. Ultrasound showed normal sized kidneys (115 mm) (American Rheumatologists' Association).
with an increase in the reflectivity. There was no evidence of Three cases of acute SLE following hepatitis B vaccine calyceal cysts. Renal histology revealed chronic tubulointerhave been reported. Symptoms appeared 15 days after the stitial nephritis with a diffuse interstitial cellular infiltrate first vaccination in two cases [1, 2] , and after the third consisting mainly of lymphocytes. There were nine glomeruli, injection in the latter [3] . Only two cases of ITP following of which two were sclerosed. Immunofluorescence was negahepatitis B vaccine (after second and third dose) have been tive. At the examination of HLA antigens, the HLA type reported [4] . In 1995, the WHO Collaborating Centre of was A1A9, B8B16, Dr3Dr9, where three HLA antigens (A1, International Drug Monitoring compiled 28 cases of throm-B8, Dr3) match with the HLA type of the siblings referred bopenia occurring after vaccination against hepatitis B [5] .
by Farrel. In contrast with them, our patient is not obese It is not possible to claim the causal link between these (47 kg, 156 cm). Blood pressure with ABPM was normal two observations and the vaccination, but the time link is with a preserved diurnal rhythm. Family history was negative impressive. These two autoimmune diseases can occur in the for renal disease. She had normal secondary sexual charactersame subject, or in the same family [6 ], a genetic predisposi-istics and normal intelligence. Furthermore, there were no tion is likely. A viral infection often precedes ITP in children, signs of the previously described renal-retinal syndromes: as for acute SLE. Vaccination introduces an antigen together medullary cystic disease, Bardet-Biedl syndrome or with adjuvants that may provoke an autoimmune type Sensenbrenner's syndrome. reaction on a genetically predisposed ground. This observaWe believe that this patient suffers from the same new tion matches the concept that flares of autoimmune diseases renal-retinal syndrome as Farrel's siblings. We think that the could be induced by hepatitis B vaccine. Only a few of the similarities and differences between the cases will help to most serious manifestations following hepatitis B vaccine know more about this syndrome. have been reported, the rate of mild autoimmune manifestations being probably largely underestimated.
Nephrological as an adjunct therapy for the treatment of meningococcal 6. Constans J, Le Herissier A, Vergnes C, Roudaut R, Durandet P, septicaemia. Nephrol Dial Transplant (1998) 13: 2422 2422 devastating illness is now receiving much attention. Reduced platelet count and coagulation profile were normal; the urea was 170 mg/dl, creatinine 7.6 mg/dl, Na 125 mEq/l, K 4.6 or even negligible protein C concentrations may lead to rapid clinical deterioration in cases of purpura fulminans. Protein mEq/l, Cl 106 mEq/l, HCO 3 21 mEq/l, Ca 8.98 mg/dl, P 4.73 mg/dl. Urine: proteinuria 1.7 g in a 24-h specimen, C infusions offer protection against the lethal effects of bacteria [2] . Elevation of protein C concentrations has been Na 32 mEq/l, macrohaematuria; urine culture negative, Ziehl-Neelsen stains and Lowestein (×3) negatives. demonstrated to be of benefit in improving the clinical course of septicaemia [2] [3] [4] . Boldt et al. [3] found that use of ECG and X-ray of the chest were normal. Renal ultrasound showed bilaterally enlarged kidneys with multiple pentoxifylline improved endothelial-related coagulation in critically ill patients, while Churchwell et al. [4] noted an cysts, lithiasis in the lower pole of the left kidney and nondilated urinary tract. The patient was diagnosed as having increase in protein C concentrations after intensive plasma exchange.
ADPKD. He was told to rest and was treated with intravenous fluids and antibiotics. After 2 weeks renal function More recently a group in Dublin (Ireland ) have seen dramatic results of patient survival in cases of meningococcal improved and the blood pressure was controlled, but since the macrohaematuria persisted further examinations were septicaemia after protein C administration (unpublished data). Possibly in this present report use of plasma exchange done. Renal sonography and abdominal computed scan: left perirenal haematoma, neither calcifications nor lymph nodes may have produced a beneficial affect to this patient through improvement in protein C concentrations.
were seen (Figure 1) ; cystoscopy and retrograde pyelography revealed bleeding from the left ureter; in intra-arterial digital Use of protein C infusions may serve as another or alternative additional therapy in the effective treatment of subtraction angiography there was no neovascularity to suggest a tumour. 
presenting with prolonged macrohaematuria and
Another noteworthy aspect of the present case was the perinephric haematoma long duration of haematuria. Macrohaematuria in ADPKD is usually self limiting in a period of not more than 7-14 days. If bleeding is prolonged for more than 2 weeks or if it Sir, develops for the first time in a patient over 50, it is recomGross haematuria is the presenting symptom in 15-20% of patients with autosomal dominant polycystic kidney disease (ADPKD) [1] . Usually it is due to haemorrhage from cysts into pyelocalyceal system. More rarely, cyst rupture may occur into the perinephric space, giving rise to a perirenal haematoma [2] . We describe the case of a patient with prolonged macrohaematuria and perinephric haematoma as the presenting features of ADPKD.
A 56-year-old man was referred to us because of dark urine that had appeared in the previous hours; he had also presented left flank pain over the last 5 days, and had taken an unmeasured amount of diclofenac; he denied having abdominal trauma. Past personal history: arterial hypertension for 20 years treated with captopril, he was a heavy smoker. Family history: a 20-year-old daughter with renal cysts. On physical examination the patient's blood pressure was 160/90 mmHg; he was afebrile; the abdomen was not painful, but irregular surfaces could be felt on palpation; the rest of the physical examination was normal.
The most significant laboratory findings were: haemo- Fig. 1 . CT abdominal scan. Enlarged kidneys with multiple cystic spaces and left perinephric haematoma.
globin 10 g/dl, leukocytes 17400/ml (neutrophils 83%), the Downloaded from https://academic.oup.com/ndt/article-abstract/13/9/2421/1808094/Protein-C-administration-in-meningococcal by guest on 15 September 2017
Nephrol Dial Transplant (1998 Transplant ( ) 13: 2423 Transplant ( 2423 mended that the possibility of malignancy should be elimin-formed with sodium pertechnetate Tc 99m, demonstrated a ated [4], as we did. Moreover, in this case lithiasis may have pattern of multinodular thyroid gland hyperplasia which is played a role in the haematuria. frequent in this endemic goitre region [3] . After treatment In conclusion, a perirenal haematoma is a rare complica-with propylthiouracil (200 mg per day) and propranolol tion of ADPKD, but it may appear even as the main form (40 mg per day), her heart rate decreased (88 beats/min) and of presentation and it may be associated with prolonged other physical signs disappeared within a few days. macrohaematuria.
ESRD is associated with a clinically euthyroid status. Although goitre and exophtalmus are well-recognized feaNephrology Section and Diagnostic A. E. Medicine 1988; 67: 187-197 which is similar to other non-thyroidal illnesses except for attenuated. In a third period, DW had to be increased due Importance of dry-weight assessment in well-being, to improved appetite, but all positive effects of period 2 were appetite, nutritional status, and anaemia correction in maintained.
haemodialysis patients
Our results suggest that a correct DW assessment is a very important factor to achieve optimal dialysis. Hypertension, Sir, anorexia and other parameters usually related to inadequate There is nowadays a growing tendency to analyse dialysis dialysis in term of Kt/V, like anaemia and malnutrition, can adequacy only in terms of Kt/V, while dry weight (DW ) be corrected by maintaining an optimal DW. Higher than assessment and normotension have been gradually omitted usual BP levels or lower IDWG can be clinical signs of mild in the goals of dialysis. However, the well-documented link overhydration in HD patients, when more obvious signs between blood pressure (BP) and patient survival [1] suggest of fluid overload as dyspnoea or oedema are absent. the need to strictly normalize blood pressure in dialysis Unexplained anaemia is often secondary to haemodilution patients, and inadequate BP control most often is due to a and can induce a misdiagnosis of Epo resistance. failure in achieve and maintain dry weight [2] . When DW is Insufficient ultrafiltration may contribute to anorexia in overestimated, overhydration develops. We observed a dialysis patients [3] due to bowel-wall oedema. Our results negative influence of mild overhydration not only on blood are in concordance with this point of view, as appetite pressure control, but also on well-being, appetite and other increased only with DW reduction in all cases. parameters, usually related to inadequate dialysis, like anaeCareful and continued clinical observation must constitute mia correction and nutritional status. To confirm this obser-the only way to achieve and maintain DW in haemodialysis vation, we selected a small group of haemodialysis patients patients. with suspicion of mild overhydration and prospectively and n-PCR) parameters were compared before (state 1) and prescription. Am J Nephrol 1996; 16: 79-89 after (state 2) DW reduction.
All patients were maintained with their usual haemodialysis prescription, adjusted to deliver a minimum Kt/V of 1 and remained unchanged during the study period. Erythropoietin Tissue factor pathway inhibitor and tissue factor in HD doses, ferritin levels, and transferrin saturation were included and CAPD in the database in the two steady states. After the initial DW reduction, we observed that DW had to be progressively Sir, increased in every patient, as cramps or intradialytic hypo-The prevalence of cardiovascular disease is high in the tension continued in a high percentage of dialysis sessions. dialysis population. It has been reported that increased All the patients reported improvement in appetite and, in fibrinogen, elevated fVIIa, deranged fibrinolytic system 3.8±0.9 months, all the patients achieved a DW similar to (increased plasma levels of PAI-inhibitor of tissue plasthe estimated basal DW. In a second part of the study, we minogen activator) may contribute to the development of compared the same parameters at this steady state (state 3) atherosclerosis or cardiovascular disease [1] . Haemostatic with state 2 and with the basal overhydrated state, in which disturbances are reported to occur in haemodialysed patients the estimated DW was the same. and in CAPD patients [2, 3] . It has been suggested by Tomura Both mean predialysis systolic and diastolic BP values et al. [1] that CAPD patients may have a greater risk of were reduced (P<0.05) in state 2 and were maintained in cardiovascular disease than HD patients, and they are more state 3. Antihypertensive therapy could be reduced or elimin-susceptible to thrombosis and atherosclerosis compared with ated in 38% of the patients. All the patients complained of HD subjects. Tissue factor plays a central role in the initiation anorexia in state 1. Appetite improved in all cases after DW of blood coagulation at the site of injury. TFPI (tissue factor reduction, as did interdialytic weight gain (IDWG), which pathway inhibitor) appears to play a primary role in the was significantly higher in states 2 and 3 (2252±722 ml in regulation of TF-induced coagulation [4] . It is primarily state 2 and 2403±790 in state 3; P<0.001 vs IDWG in synthesized by the endothelium under normal physiological state 1). Haemoglobin level also increased in state 2 conditions [4] . Two, recently, published reports about TFPI (11.7±1.03 vs 9.6±0.9 g/dl in state 1; P<0.001) and was [5, 6 ] levels in haemodialyzed patients yielded conflicting maintained unchanged (12.2±0.83 g/dl ) in state 3, without results. Considering all these data, we aimed to assess TF changes in the dose of erythropoietin, or iron stores. Dialysis and TFPI levels and activities in patients maintained on HD schedule remained unchanged (similar Kt/V ) but appetite and CAPD. Thrombomodulin as a marker of endothelial improved in all cases, n-PCR increased (P<0.001) in states cell injury was also studied in these groups of patients. 2 and 3, as did serum albumin (P<0.001) and s-transferrin
The studies were performed on 20 chronically haemoconcentration (P<0.005 vs state 1).
dialysed patients (12 men, 8 women, age range 31-65) In summary, correction of DW in our patients was undergoing 4-5 h of haemodialysis three times a week for followed by a reduction in BP, increase in appetite and bio-over 6 months and 9 CAPD subjects (6 men, 3 women, age range 20-53). CAPD patients were on 4×21 exchanges chemical signs of improved nutrition. Anaemia was also (Baxter Twin bag system or Andy Plus, Fresenius system). FVIIa may also be generated by endothelial cell injury in uremic patients [7] . The increased levels of other markers of Dwell times were generally 4-6 h during the day and 8 h overnight. The osmotic pressure of CAPD fluid was adjusted endothelial cell damage as vWF, thrombomodulin, tissue plasminogen activator/plasminogen activator inhibitor 1 in accordance with the extent of ultrafiltration in each patient. Peritonitis has not occurred in any of the patients complexes found in uraemia in previous studies [8] are in keeping with this concept. TFPI is a potent inhibitor of the during the 3 month period before the study. Ten volunteers without any apparent disease or abnormalities on routine factor VIIa/TF complex in the presence of factor Xa, as well as being a direct inhibitor of FXa [4] . This high level of laboratory tests served as a control group. Blood samples from haemodialysed patients were collected into 3.8% trisod-TFPI might thus counterbalance the increased levels of FVIIa in uraemia and may be seen as a defence mechanism ium citrate (9 vol of blood to 1 vol of 0.13 M of trisodium citrate solution) from the arterial side of the a-v fistula before against a hypercoagulable state, particularly in CAPD. We have also found an increased TF activity in both groups of the onset of haemodialysis and heparin administration. To avoid the influence of circadian variation all the samples dialysed patients. Recently, plasma TF levels have been found to be increased in chronically haemodialysed patients were taken in the morning between 8 and 9 a.m. Samples were then centrifuged at 3000 g for 20 min at room temper- [9] , whereas in non-dialysed patients results are conflicting [7, 9] . Since it is unclear how closely TF antigen corresponds ature within 1 h of collection to yield platelet poor plasma. Then plasma was subsequently aliquotted and stored in to TF procoagulant activity, we decided to measure TF activity in CAPD and haemodialysed patients. TF activity plastic tubes at −40°C until assayed. TF, TFPI activities and antigens, thrombomodulin concentration were per-was significantly higher in CAPD patients when compared to haemodialysed patients but similar to the healthy volunformed using commercially available kits from American Diagnostica, USA. Analysis of variance was used for compar-teers. Plasma TF has been reported to have FVII-dependent procoagulant activity in vitro [10] . However, it is not clear ison of mean values between groups studied. A P<0.05 was taken to indicate statistical significance.
whether plasma fraction of TF with procoagulant activity or TF locally expressed on the injured renal endothelium might The results are shown in Table 1 . TF activity was significantly higher in CAPD patients when compared to haemodia-mediate FVIIa generation.
Concluding, our data further suggest the evidence of lysed patients but similar to the healthy volunteers. TF levels were higher in both groups of dialysed patients relative to endothelial injury in uraemic patients treated by means of CAPD or haemodialyses. Further insights into the impacts control group. TFPI activity was significantly higher in both groups of dialysed patients, whereas TFPI levels, although of perturbed endothelium in vivo will undoubtedly help to improve our knowledge about pathophysiology of thromhigher, did not reach statistical significance when compared to healthy subjects. Thrombomodulin concentrations were botic events and their complications in uraemia as well as their prevention and therapy. significantly higher in CAPD and haemodialysed patients when compared to healthy subjects.
Department of Nephrology Jolanta Małyszko So far there have been no data concerning TF and TFPI and Internal Medicine Jacek S. Małyszko in CAPD patients. Concerning haemodialysed patients, our University School of Medicine Michal Myśliwiec data are in contrast to those of Cella et al. [5] who did not Bialystok observe any differences in TFPI activity between chronically Poland haemodialysed patients and healthy subjects. Similar data to 1. Tomura S, Nakamura Y, Doi M et al. Fibrinogen, coagulation ours were published by Kario et al. [6 ] who reported an factor VII, tissue plasminogen activator, plasminogen activator increased plasma TFPI activity before dialysis. In our study inhibitor-1, and lipid as cardiovascular risk factor in chronic we found that not only TFPI activity but also TFPI antigen hemodialysis and continuous ambulatory peritoneal dialysis was increased in haemodialysed patients. This could be due patients. Am J Kidney Dis 1996; 27: 848-854 to a reduced kidney catabolism or to endothelial cell damage. percentage urea reduction across a single haemodialysis treatment, was used to anonymously compare the quality of dialysis provided in the 11 adult dialysis units in Scotland. be too low and that a >60% urea reduction rate might At that time the Renal Association of the UK recommended be more appropriate [1] . In November 1997 the Renal a minimum standard for percentage urea reduction of >55 Association reviewed and revised the recommended stand- [2] . By the end of the audit cycles all units except for one, ards and audit measures for treatment of adult patients with Unit 4, had more than 80% of their patients achieving the renal failure in the UK [3] . For patients on thrice weekly minimum standard. The question was raised as to how haemodialysis a minimum standard percentage urea reducassistance could be offered to this unit while retaining the tion of >65% was recommended. On reviewing the data anonymity incorporated into audit.
from the audit cycle of April 1997 only 59% of the 653 When the audit cycle was repeated in April 1997, 89% of patients on hospital haemodialysis in Scotland reached a the 653 patients on hospital haemodialysis in Scotland >65% urea reduction. No unit managed to achieve a level achieved a urea reduction >55% (Figure 1 ). Again >80% of 80% patients reaching a urea reduction of >65% and in of patients in each unit, apart from one, achieved the required three units only around one-third of patients achieved this minimum standard but on this occasion Unit 4 had reached level (Figure 3 ). The degree of shortfall in the levels of urea this level and a different unit had fallen below the 80% level reduction achieved suggests that the only effective way of (Figure 2 ). Regular audit, therefore, does appear to have ensuring that >80% of patients achieve the minimum standhelped to improve the quality of hospital haemodialysis being ard will be by significantly lengthening dialysis times, conprovided without a breach of anonymity.
sequently affecting dialysis shift patterns. Repeated audit The Scottish Renal Registry suggested that the minimum standard of a percentage urea reduction value of >55 might of >65 in the 11 adult dialysis units in Scotland.
